OR WAIT null SECS
October 23, 2026
Article
Diana Isaacs, PharmD, and Natalie Bellini, DNP, review early MiniMed Vivera data on optional meal announcements and twiist's new type 2 diabetes clearance.
October 15, 2026
Podcast
Diana Isaacs, PharmD, and Natalie Bellini, DNP, recap the first-ever Breakthrough T1D Clinical and Research Congress.
October 06, 2026
Video
Buse discusses the shortcomings of current CGM and AID technologies, as well as how current research aims to address them and further reduce hypoglycemia risk.
October 02, 2026
Stay up-to-date with the latest in FDA decisions, trial readouts, and key clinician insights from all corners of endocrinology.
September 25, 2026
In this segment from the latest episode of Diabetes Dialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss UACR screening for patients with CKD and T1D.
September 22, 2026
In this segment from the latest episode of Diabetes Dialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the FDA's recent approval of finerenone for CKD with T1D.
September 18, 2026
Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the FDA's recent approval of Bayer's finerenone in concomitant CKD and T1D.
September 17, 2026
The approval, backed by FINE-ONE data showing a 28% UACR reduction at 6 months, is the first new CKD treatment for this group in 3 decades.
September 15, 2026
Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss Beta Bionics' new insulin patch pump, expected to be commercialized in Q1 2027.
September 14, 2026
Beta Bionics plans to launch Mint through the pharmacy channel in the first quarter of 2027.
